Improving computer models for studying protein interactions in Alzheimer's disease
Solvation modeling for next-gen biomolecule simulations
This study is working on improving computer models that help us understand how proteins interact in the brain, especially for people with Alzheimer's, which could lead to better treatments for the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University New York Stony Brook NIH-funded |
| Lab location | 1 site (Stony Brook, United States) |
| Project ID | NIH-10876947 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy and speed of computer models used to simulate how proteins interact, particularly in the context of Alzheimer's disease. By integrating various scientific approaches, the team aims to develop better methods for predicting how proteins bind and behave in biological systems. This could lead to improved drug discovery processes and therapeutic solutions for conditions related to protein aggregation, such as Alzheimer's. Patients may benefit from advancements in treatments that target these complex protein interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with conditions unrelated to protein aggregation or those not diagnosed with Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Alzheimer's disease and related conditions by improving our understanding of protein interactions.
How similar studies have performed: Other research in computational biophysics has shown promise in improving drug discovery and understanding protein interactions, indicating that this approach could yield significant advancements.
Where this research is happening
Stony Brook, United States
- State University New York Stony Brook — Stony Brook, United States (Active)
Researchers
- Principal investigator: Dill, Ken a — State University New York Stony Brook
- Study coordinator: Dill, Ken a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.